These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 29499491)
21. Substrate inhibition kinetic model for West Nile virus NS2B-NS3 protease. Tomlinson SM; Watowich SJ Biochemistry; 2008 Nov; 47(45):11763-70. PubMed ID: 18855422 [TBL] [Abstract][Full Text] [Related]
22. NMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B-NS3 protease. Su XC; Ozawa K; Yagi H; Lim SP; Wen D; Ekonomiuk D; Huang D; Keller TH; Sonntag S; Caflisch A; Vasudevan SG; Otting G FEBS J; 2009 Aug; 276(15):4244-55. PubMed ID: 19583774 [TBL] [Abstract][Full Text] [Related]
23. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease. Dwivedi VD; Tripathi IP; Mishra SK J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586 [TBL] [Abstract][Full Text] [Related]
24. Attenuation of West Nile Virus NS2B/NS3 Protease by Amino Terminal Copper and Nickel Binding (ATCUN) Peptides. Pinkham AM; Yu Z; Cowan JA J Med Chem; 2018 Feb; 61(3):980-988. PubMed ID: 29301071 [TBL] [Abstract][Full Text] [Related]
25. Identification of a 3-Alkylpyridinium Compound from the Red Sea Sponge O'Rourke A; Kremb S; Duggan BM; Sioud S; Kharbatia N; Raji M; Emwas AH; Gerwick WH; Voolstra CR Molecules; 2018 Jun; 23(6):. PubMed ID: 29912151 [TBL] [Abstract][Full Text] [Related]
26. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells. Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156 [TBL] [Abstract][Full Text] [Related]
27. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity. Stoermer MJ; Chappell KJ; Liebscher S; Jensen CM; Gan CH; Gupta PK; Xu WJ; Young PR; Fairlie DP J Med Chem; 2008 Sep; 51(18):5714-21. PubMed ID: 18729351 [TBL] [Abstract][Full Text] [Related]
28. Discovery and SAR studies of methionine-proline anilides as dengue virus NS2B-NS3 protease inhibitors. Zhou GC; Weng Z; Shao X; Liu F; Nie X; Liu J; Wang D; Wang C; Guo K Bioorg Med Chem Lett; 2013 Dec; 23(24):6549-54. PubMed ID: 24268549 [TBL] [Abstract][Full Text] [Related]
29. Identification of palmatine as an inhibitor of West Nile virus. Jia F; Zou G; Fan J; Yuan Z Arch Virol; 2010 Aug; 155(8):1325-9. PubMed ID: 20496087 [TBL] [Abstract][Full Text] [Related]
30. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal. Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519 [TBL] [Abstract][Full Text] [Related]
31. Discovery of Nanomolar Dengue and West Nile Virus Protease Inhibitors Containing a 4-Benzyloxyphenylglycine Residue. Behnam MA; Graf D; Bartenschlager R; Zlotos DP; Klein CD J Med Chem; 2015 Dec; 58(23):9354-70. PubMed ID: 26562070 [TBL] [Abstract][Full Text] [Related]
32. Detection and in-cell selectivity profiling of the full-length West Nile virus NS2B/NS3 serine protease using membrane-anchored fluorescent substrates. Condotta SA; Martin MM; Boutin M; Jean F Biol Chem; 2010 May; 391(5):549-59. PubMed ID: 20302513 [TBL] [Abstract][Full Text] [Related]
33. High-throughput virtual screening lead to discovery of non-peptidic inhibitors of West Nile virus NS3 protease. Huang D Methods Mol Biol; 2012; 819():615-23. PubMed ID: 22183561 [TBL] [Abstract][Full Text] [Related]
34. Transplantation of a hydrogen bonding network from West Nile virus protease onto Dengue-2 protease improves catalytic efficiency and sheds light on substrate specificity. Doan DN; Li KQ; Basavannacharya C; Vasudevan SG; Madhusudhan MS Protein Eng Des Sel; 2012 Dec; 25(12):843-50. PubMed ID: 22972763 [TBL] [Abstract][Full Text] [Related]
35. West Nile Virus (WNV) protease and membrane interactions revealed by NMR spectroscopy. Gayen S; Chen AS; Huang Q; Kang C Biochem Biophys Res Commun; 2012 Jul; 423(4):799-804. PubMed ID: 22713461 [TBL] [Abstract][Full Text] [Related]
36. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006 [TBL] [Abstract][Full Text] [Related]
37. A P2 and P3 substrate specificity comparison between the Murray Valley encephalitis and West Nile virus NS2B/NS3 protease using C-terminal agmatine dipeptides. Ang MJ; Li Z; Lim HA; Ng FM; Then SW; Wee JL; Joy J; Hill J; Chia CS Peptides; 2014 Feb; 52():49-52. PubMed ID: 24333681 [TBL] [Abstract][Full Text] [Related]
38. Discovery of a non-peptidic inhibitor of west nile virus NS3 protease by high-throughput docking. Ekonomiuk D; Su XC; Ozawa K; Bodenreider C; Lim SP; Yin Z; Keller TH; Beer D; Patel V; Otting G; Caflisch A; Huang D PLoS Negl Trop Dis; 2009; 3(1):e356. PubMed ID: 19159012 [TBL] [Abstract][Full Text] [Related]
39. Development and characterization of new peptidomimetic inhibitors of the West Nile virus NS2B-NS3 protease. Hammamy MZ; Haase C; Hammami M; Hilgenfeld R; Steinmetzer T ChemMedChem; 2013 Feb; 8(2):231-41. PubMed ID: 23307694 [TBL] [Abstract][Full Text] [Related]
40. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases. Nitsche C; Steuer C; Klein CD Bioorg Med Chem; 2011 Dec; 19(24):7318-37. PubMed ID: 22094280 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]